Literature DB >> 35834329

Letter: Commentary: Cost-Effectiveness Analysis of Encephaloduroarteriosynangiosis Surgery for Symptomatic Intracranial Atherosclerotic Disease.

Nestor R Gonzalez1, Miguel D Quintero-Consuegra.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35834329      PMCID： PMC9514757          DOI： 10.1227/neu.0000000000002056

Source DB:  PubMed          Journal:  Neurosurgery        ISSN： 0148-396X            Impact factor:   5.315


× No keyword cloud information.
  20 in total

1.  Cost analysis of erlotinib versus chemotherapy for first-line treatment of non-small-cell lung cancer in frail elderly patients participating in a prospective phase 2 study (GFPC 0505).

Authors:  Christos Chouaid; Hervé Le Caer; Romain Corre; Jacquy Crequit; Chrystelle Locher; Lionel Falchero; Cecile Dujon; Henri Berard; Isabelle Monnet; Alain Vergnenegre
Journal:  Clin Lung Cancer       Date:  2012-06-07       Impact factor: 4.785

2.  A strategy for collecting pharmacoeconomic data during phase II/III clinical trials.

Authors:  J Mauskopf; K Schulman; L Bell; H Glick
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

3.  Medicine's ethical responsibility for health care reform--the Top Five list.

Authors:  Howard Brody
Journal:  N Engl J Med       Date:  2009-12-23       Impact factor: 91.245

4.  A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study).

Authors:  C Sebban; A Lefranc; L Perrier; P Moreau; D Espinouse; A Schmidt; L Kammoun; H Ghesquieres; C Ferlay; J O Bay; S Lissandre; D Pérol; M Michallet; P Quittet
Journal:  Eur J Cancer       Date:  2012-01-14       Impact factor: 9.162

5.  Cost-effectiveness analysis of intracranial stent placement versus contemporary medical management in patients with symptomatic intracranial artery stenosis.

Authors:  Amir Khan; Ameer Hassan; Fareed Suri; Adnan Qureshi
Journal:  J Vasc Interv Neurol       Date:  2013-12

6.  Healthy Beginnings Trial Phase 2 study: follow-up and cost-effectiveness analysis.

Authors:  Li Ming Wen; Louise A Baur; Chris Rissel; Vicki Flood; Judy M Simpson; Alison Hayes; Louise L Hardy; Karen Wardle
Journal:  Contemp Clin Trials       Date:  2011-11-11       Impact factor: 2.226

7.  Reorganizing patient care and workflow in the operating room: a cost-effectiveness study.

Authors:  James E Stahl; Warren S Sandberg; Bethany Daily; Richard Wiklund; Marie T Egan; Julian M Goldman; Keith B Isaacson; Scott Gazelle; David W Rattner
Journal:  Surgery       Date:  2006-06       Impact factor: 3.982

8.  Cost-Effectiveness Analysis of Encephaloduroarteriosynangiosis Surgery for Symptomatic Intracranial Atherosclerotic Disease.

Authors:  Nestor R Gonzalez; Miguel D Quintero-Consuegra; Julie L Chan; Daniel Chang; Chi-Hong Tseng; Jeffrey L Saver
Journal:  Neurosurgery       Date:  2022-04-01       Impact factor: 5.315

9.  Commentary: Cost-Effectiveness Analysis of Encephaloduroarteriosynangiosis Surgery for Symptomatic Intracranial Atherosclerotic Disease.

Authors:  Gavin W Britz; Jonathan J Lee
Journal:  Neurosurgery       Date:  2022-05-01       Impact factor: 5.315

10.  Cost-Effectiveness Analysis of Stereotactic Ablative Radiation Therapy in Patients With Oligometastatic Cancer.

Authors:  Abhishek Kumar; Christopher Straka; Patrick T Courtney; Lucas Vitzthum; Paul Riviere; James D Murphy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-09-28       Impact factor: 7.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.